NASDAQ: BCPCBalchem Corp Stock Ownership - Who owns Balchem?
Insider buying vs selling
Have Balchem Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gunsteren Job Leonard Van | SVP and GM Specialty Products | 2024-07-31 | 3,750 | $60.85 | $228.19kBuy |
| Gunsteren Job Leonard Van | SVP and GM Specialty Products | 2024-07-31 | 7,750 | $180.05 | $1.40MSell |
| Gunsteren Job Leonard Van | SVP and GM Specialty Products | 2024-07-31 | 4,000 | $58.52 | $234.08kBuy |
| William A. Backus | VP Chief Accounting Officer | 2024-07-30 | 904 | $177.10 | $160.09kSell |
| William A. Backus | VP Chief Accounting Officer | 2024-07-30 | 330 | $180.47 | $59.55kSell |
| William A. Backus | VP Chief Accounting Officer | 2024-07-30 | 3,900 | $84.09 | $327.95kBuy |
| William A. Backus | VP Chief Accounting Officer | 2024-07-30 | 3,570 | $179.25 | $639.91kSell |
| Hatsuki Miyata | EVP Gen. Counsel Secretary | 2024-07-27 | 616 | $180.78 | $111.36kSell |
| Michael Robert Sestrick | SVP Chief Technology Officer | 2024-05-10 | 1,929 | $154.45 | $297.93kSell |
| David B. 1. Fischer | Director | 2024-05-08 | 4,363 | $152.85 | $666.87kSell |
BCPC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BCPC insiders and whales buy or sell their stock.
BCPC Shareholders
What type of owners hold Balchem Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 15.27% | 4,965,398 | $787.61M | Institution |
| Blackrock Inc 1 | 15.27% | 4,965,398 | $787.61M | Institution |
| Vanguard Group Inc | 12.05% | 3,918,794 | $621.60M | Institution |
| Apg Asset Management Nv | 8.52% | 2,768,378 | $439.12M | Institution |
| Wasatch Advisors LP | 4.17% | 1,355,118 | $214.95M | Institution |
| State Street Corp | 3.80% | 1,234,226 | $195.77M | Institution |
| Conestoga Capital Advisors LLC | 3.62% | 1,175,569 | $186.47M | Institution |
| Geode Capital Management LLC | 2.86% | 928,904 | $147.34M | Institution |
| Geneva Capital Management LLC | 2.40% | 779,869 | $123.70M | Institution |
| Morgan Stanley | 2.36% | 768,287 | $121.87M | Institution |
BCPC vs Specialty Chemical Stocks
Balchem Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.